Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Romania: Flying High

06/10/2015Romania: Flying High

For almost 25 years, Deloitte Romania has been offering customers high quality services thanks to its extensive knowledge, innovation, experience and wide range of services.

How Your Medicines Are Put To The Test

16/02/2024How Your Medicines Are Put To The Test

Ever wondered about the incredible journey your medicines undertake before landing in your pharmacy bag? It’s a fascinating process of scientific rigor, safety assurance, and constant innovation that shows the untold stories behind the pills we often tak

How to Hire a Virtual Assistant: A Practical Guide for Businesses

30/04/2026How to Hire a Virtual Assistant: A Practical Guide for Businesses

Microsoft’s Work Trend Index says Microsoft 365 users are interrupted every two minutes by meetings, email, or notifications. That isn’t just a productivity issue. It shows how quickly small tasks can break a leader’s focus. A virtual assista

Lower Profits at Brazil’s Foreign Banks Limit Expansion

16/02/2015Lower Profits at Brazil’s Foreign Banks Limit Expansion

Reduced profits from capital market-related activities to hold back plans for expansion in the country.

Delivering Quality on a Global Basis

01/03/2018Delivering Quality on a Global Basis

Giambrone is an international law firm with offices in London, Barcelona, Glasgow, Mallorca, Milan, Munich, Palermo, Rome, Sardinia, and Tunis.

How to Handle a Contentious Probate Dispute When a Business Owner Dies Without a Clear Will

31/07/2026How to Handle a Contentious Probate Dispute When a Business Owner Dies Without a Clear Will

When a business owner passes away without leaving a clear will, families go through many challenges. For instance, families might suddenly find themselves arguing over who owns the business now and who is best positioned to make decisions. Disagreements like t

The Pros & Cons of Employee Stock Ownership Plans

02/03/2016The Pros & Cons of Employee Stock Ownership Plans

An Employee Stock Ownership Plan and Trust (ESOP) can produce greater commitment and productivity from employees and, in turn, greater fair market value of a corporation, provided that employees understand how their work affects the creation of such value.

Empowering Your Accounting Software with AI Capabilities

03/01/2024Empowering Your Accounting Software with AI Capabilities

According to a recent study by KPMG, over 59% of large organizations already use AI in their financial, accounting, and tax departments and about 29% plan to implement AI-powered software within the next 12 months.

How Smart Technologies Are Transforming Industrial Workspaces Safely and Efficiently

26/02/2026How Smart Technologies Are Transforming Industrial Workspaces Safely and Efficiently

Operations directors, EHS managers, and facility leaders in traditional industrial environments are running into the same wall: the impact of outdated industrial technology makes everyday decisions slower, riskier, and harder to standardize.

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS